Skip to main content

Table 1 Schedule of activities for the CS003-BC phase II clinical study

From: Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC)

Schedule of activities

Time point

Enrolment

Initial Visit and chemotherapy cycle 1 (Anthracyclines)

Cycle 2–4 (Anthracyclines)

Cycle 5—8 (Taxanes)

Close-out

Enrolment

 Screening and Informed Consent

X

    

 Physical Examen

 

X

X

X

X

 Clinical Record

 

X

X

X

X

 HIV Test and Pregnancy test

X

    

Interventions

 Medication dispensing

 

X

X

X

X

 Follow-up visit

 

X

X

X

X

Safety Assessment

 Hemogram

 

X

X

X

X

 Transaminase AST

 

X

X

X

X

 Transaminase ALT

 

X

X

X

X

 Alkaline Phosphatase

 

X

X

X

X

 Total Bilirubin

 

X

X

X

X

 Triglycerides

 

X

X

X

X

 Electrocardiograma

 

X

X

 

X

 Echocardiograma

 

X

X

 

X

Efficacy Assessment

 RECISTa

 

X

X

 

X

 Metabolomea

 

X

X

 

X

 Microbiome Analysisa

 

X

X

 

X

 Tumor Infiltratea

 

X

X

 

X

 Progression-Free Survival

    

X

 QLQ C-30 Quality of Life Surveys

 

X

X

 

X

 QLQ BR-23 Quality of Life Surveys

 

X

X

 

X

  1. aThe mentioned tests will be conducted at three specific time points: before initiating treatment, at the completion of the anthracycline cycle, and at the conclusion of the taxane cycle. Other activities will be performed prior to initiating each cycle or as requested by the researcher for safety assessment purposes